The European Federation of Pharmaceutical Industries and Associations statement on antimicrobial resistance problem
The European Federation of Pharmaceutical Industries and Associations (EFPIA) strongly welcomes the approval of their own initiative report on “A European One Health Action Plan against Antimicrobial Resistance” by the Environment, Public Health and Food Safety (ENVI) Committee of the European Parliament on the 20th June 2018.
The Committee of the European Parliament appeals to the European Commission and the Member States encouraging them to support and adopt new economic models and experimental pilot projects so that to stimulate the development of new antimicrobials, vaccines and rapid diagnostic tests. These aspects are the main measures that should be taken to effectively combat with antimicrobial resistance.
Therefore, EFPIA and its’ members especially support any activities which aim to boost the development of new antimicrobial drugs, vaccines and rapid diagnostic tools. The Federation is positive that European policy makers should work in conjunction with public and private researchers in order to find ways to increase the number of antimicrobials under development.
It is pointed out in the report that correct and prudent use of antimicrobials is crucial for controlling the resistance. They also do believe that the European Commission should manage and share practical guidelines among Member States and stimulate EU countries to implement resolute national strategies against antimicrobial resistance.
The ENVI Committee is calling the European Commission and EU members to join their efforts together and coordinate monitoring and reporting of any new information on antimicrobial resistance problem.
Link: EFPIA
